Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126335232 | 12633523 | 2 | F | 201605 | 20160912 | 20160808 | 20160916 | EXP | PHHY2016BR108738 | NOVARTIS | 84.38 | YR | M | Y | 56.00000 | KG | 20160916 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126335232 | 12633523 | 1 | PS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF, QD | 1513199 | 21283 | 1 | DF | TABLET | QD | |||||
| 126335232 | 12633523 | 2 | SS | DIOVAN TRIPLE | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEVALSARTAN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126335232 | 12633523 | 1 | Hypertension |
| 126335232 | 12633523 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126335232 | 12633523 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126335232 | 12633523 | Blood pressure abnormal | |
| 126335232 | 12633523 | Gastric disorder | |
| 126335232 | 12633523 | Hypertension | |
| 126335232 | 12633523 | Lung disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |